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Cytotoxic T-lymphocytes (CTL) are essential for 
limiting and clearing viral infections (Doherty   
et al., 1992). CTLs are restricted by class I MHC 
molecules, which are a frequent target of viral 
strategies for their down-regulation or even elim-
ination. The unique short region of human cyto-
megalovirus (HCMV) genome contains the 
US2-US11 genes, a region predicted to encode at 
least eight small glycoproteins of only limited ho-
mology (Weston and Barrell, 1986; Kouzarides   
et al., 1988). Several of them interfere with class I 
MHC–restricted  antigen  presentation,  through 
inhibition of the MHC-encoded TAP peptide 
transporter (HCMV US6; Ahn et al., 1997; Jun   
et al., 2000), retention of newly synthesized class I 
MHC products at their site of synthesis (HCMV 
US3; Jones et al., 1996; Jun et al., 2000), or dislo-
cation of class I MHC products from the endo-
plasmic  reticulum  (HCMV  US2  and  HCMV 
US11; Jones et al., 1996; Wiertz et al., 1996a,b;   
Machold et al., 1997; Schust et al., 1998). The co-
ordinate regulation of the genes contained in the 
unique short region protein (US) region and the 
common theme of interference with class I 
MHC–restricted antigen presentation suggest the 
possibility that other members of the family, with 
as yet poorly defined functions, may affect class I 
MHC antigen presentation as well.
For US8 and US10, a physical interaction 
with classical class I MHC products occurs   
(Furman et al., 2002; Tirabassi and Ploegh, 2002), 
but neither show significant ER retention or 
down-regulation of class I MHC products to the 
extent seen for US3, US2, and US11. Although 
both  US8  and  US10  bind  to  classical  class  I 
MHC products, only the expression of US10 
imposes a delay on their egress from the ER, 
without affecting overall turnover of assembled 
class I MHC complexes or free class I MHC 
heavy chains. Based on our experience with the 
US2 and US11 products, the observation win-
dow of these experiments was limited to short 
periods only, and was thus biased against the 
possibility of documenting changes that occur 
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Human cytomegalovirus (HCMV) encodes an endoplasmic reticulum (ER)-resident trans-
membrane glycoprotein, US10, expressed early in the replicative cycle of HCMV as part of 
the same cluster that encodes the known immunoevasins US2, US3, US6, and US11.  
We show that US10 down-regulates cell surface expression of HLA-G, but not that of 
classical class I MHC molecules. The unique and short cytoplasmic tail of HLA-G (RKKSSD) 
is essential in its role as a US10 substrate, and a tri-leucine motif in the cytoplasmic tail  
of US10 is responsible for down-regulation of HLA-G. Both the kinetics of HLA-G degrada-
tion and the mechanisms responsible appear to be distinct from those used by the US2 and 
US11 pathways, suggesting the existence of a third route of protein dislocation from the 
ER. We show that US10-mediated degradation of HLA-G interferes with HLA-G–mediated 
NK cell inhibition. Given the role of HLA-G in protecting the fetus from attack by the 
maternal immune system and in directing the differentiation of human dendritic cells to 
promote the evolution of regulatory T cells, HCMV likely targets the HLA-G–dependent  
axis of immune recognition no less efficiently than it interferes with classical class I  
MHC–restricted antigen presentation.
© 2010 Park et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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with slower kinetics, yet are quantitatively significant. These 
experiments also failed to take into account the possibility that 
some of the HCMV US gene products might target nonclassi-
cal class I MHC products, by analogy of the effects reported for 
US2 and HFE, a class I–like molecule involved in the traf-
ficking of the transferrin receptor (Ben-Arieh et al., 2001; 
Vahdati-Ben Arieh et al., 2003).
HLA-G is a particularly interesting nonclassical class I MHC 
molecule. It shows restricted tissue distribution and has limited 
polymorphism (Shawar et al., 1994; Carosella et al., 2000). 
HLA-G has strong immunomodulatory properties with specific 
relevance at immune-privileged sites such as the trophoblast or 
thymus, and it inhibits proliferation of T cells (Riteau et al., 
1999; Lila et al., 2001), natural killer cells (Pazmany et al., 1996; 
Rouas-Freiss et al., 1997; Khalil-Daher et al., 1999), and antigen- 
specific T cell cytotoxicity (Le Gal et al., 1999; Wiendl et al., 
2002). HLA-G has aroused interest not only because of its   
role in feto-maternal interactions, but also because of its expres-
sion on subsets of human dendritic cells, in particular those im-
plicated in the activation of regulatory T cells (Liang et al., 
2008; Pazmany et al., 1996).
We report that, unlike any previously described nonclassi-
cal class I product, HLA-G is sensitive to proteasomal degrada-
tion in a HCMV US10-dependent manner. The underlying 
mode of degradation of HLA-G under the agency of US10 
appears to be unique, despite similar subcellular localization 
and structural relatedness of US10 to US2 and US11. We sug-
gest that HCMV-infected cells avail themselves of all possibili-
ties to frustrate class I MHC–restricted antigen presentation, 
including the inhibition of pathways that concern nonclassical 
class I MHC products in the context of an HCMV infection.
RESULTS
HCMV US10 down-regulates surface presentation of JEG3-
derived HLA-G by degradation
Although HCMV US10 binds to classical class I MHC mole-
cules and delays their trafficking (Furman et al., 2002), it does 
not affect their steady–state cell surface levels (Ahn et al., 1997). 
To test whether US10 could interfere with the synthesis and 
stability of nonclassical class I MHC products, we expressed 
US10 in the HLA-G–positive choriocarcinoma cell line JEG3 
and examined surface levels of HLA-G by cytofluorimetry   
using W6/32 or MEM-G/9, both of which recognize assembled 
heterodimers of heavy chain and 2-microglobulin (2m;   
Fig. 1 A). We observed a significant reduction of surface ex-
pression of HLA-G in US10-expressing cells, whereas intro-
duction of US9, used as a control, was without effect on HLA-G 
levels (Fig. 1 A, right). The effect of US10 on HLA-G expres-
sion is not unique to the naturally HLA-G–expressing chorio-
carcinoma cell line JEG3. Introduction of HLA-G into HeLa 
cells showed that US10 also down-regulates HLA-G in this set-
ting (Fig. 1 B, top). US10 did not affect surface display of 
the classical class I MHC products endogenous to HeLa cells   
(Fig. 1 B, bottom). This result suggests that properties intrinsic to 
US10 are sufficient to account for down-regulation of HLA-G, 
and that no choriocarcinoma-specific factors contribute.
Figure 1.  US10 down-regulates HLA-G molecules, but not classical 
class I MHC products, by degradation. (A) Cell surface expression of  
HLA-G in HCMV US9 and US10-expressing JEG3 cells. JEG3 was transiently 
transfected with empty vector, US9, or US10. After 48 h, cell surface expres-
sion of HLA-G was monitored by cytofluorimetry using mAb MEM-G/9.  
(B) US10 down-regulates HLA-G products. Both US10 and HLA-G or US10 
alone were transiently transfected into HeLa cells. Surface expression of 
HLA-G or classical class I MHC was measured by cytofluorimetry using 
MEM-G/9 or W6/32. (C) Human foreskin fibroblasts (HFF) stably expressing 
HLA-G were infected with wild-type HCMV AD169 (a and c, shaded area), a 
HCMV mutant US2-US11 (a–d, solid black line), or RV670 (b and d, shaded 
area). Surface levels of either classical class I MHC or HLA-G by cytofluorim-
etry using W6/32 or MEM-G/9. US10 gene product is verified by RT-PCR in 
a HCMV AD169 or mutant virus-infected cells. The data shown are repre-
sentative of two independent experiments with similar results.JEM VOL. 207, August 30, 2010 
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US10-expressing cells (Fig. 2 C, lane 6). Inclusion of ZL3VS 
prevented the loss of labeled HLA-G in US10-expressing 
cells. Moreover, we observed a deglycosylated intermediate 
reminiscent of what is seen in US2 or US11-expressing cells 
for classical class I MHC products (Fig. 2 C, lanes 8 and 9). 
We obtained similar results for HeLa cell transfectants that 
express HLA-G and US10 (Fig. 2 D, lanes 8 and 9). We   
conclude that inclusion of proteasome inhibitors allows the 
visualization of the deglycosylated HLA-G intermediate in 
cells that express US10.
To ascertain the physiological relevance of US10 activities in 
down-regulation of HLA-G, we examined whether US10 af-
fects cell surface levels of HLA-G in the context of HCMV in-
fection. Human foreskin fibroblasts stably expressing HLA-G 
were infected either with wild-type HCMV AD169, a HCMV 
deletion mutant lacking the US2-US11 region (US2-US11), 
or with a HCMV mutant virus, RV670, lacking all genes in the 
US2-US11 region with the exception of US10 (Jones and   
Muzithras, 1992; Jones et al., 1995). We then examined surface 
levels of either classical class I MHC or HLA-G by cytofluorim-
etry using W6/32 or MEM-G/9. In AD169-infected cells,   
surface levels of classical class I MHC and HLA-G were signifi-
cantly reduced, whereas in US2-US11 AD169-infected cells 
(Fig. 1 C, a and c), they were comparable to levels observed in 
uninfected cells (Fig. 1 C). The HCMV mutant virus, RV670, 
down-regulated cell surface expression of HLA-G (Fig. 1 C, d), 
but did not affect levels of classical class I MHC products 
(Fig. 1 C, b). RV670-infected cells express the US10 gene pro-
duct as do wild-type HCMV AD169-infected cells (Fig. 1 C, 
bottom). These findings show that US10 specifically down-
regulates HLA-G, but not classical class I MHC products.
US10-dependent degradation of HLA-G involves  
a deglycosylated intermediate in the presence  
of proteasome inhibitor
To explore how US10 affects expression of HLA-G, we in-
stalled an HA epitope tag on US3, US9, and US10 to assess the 
levels of these HCMV products in transfectants. The use of the 
HA tag allowed us to select transfectants with comparable levels 
of expression for each of the viral products, as they are detected 
by one and the same antibody (Fig. 2 A). We quantitated the 
amount of HLA-G in US3-, US9-, and US10-expressing JEG3 
cells by immunoblotting using MEM-G/1 antibody, which rec-
ognizes the denatured 1 domain of HLA-G. HLA-G was barely 
detectable in the JEG3-US10 cells, but neither US3 nor US9 af-
fected the robust HLA-G levels present in these transfectants 
(Fig. 2 A). We confirmed the results of immunoblotting by bio-
chemical analysis on [35]S-methionine and cysteine-labeled cells. 
In the absence of US10, significant amounts of HLA-G were 
detected at the end of both the pulse and the 6-h chase. In con-
trast, in JEG3 cells transfected with US10, despite similar rates of 
synthesis of HLA-G during the 30-min pulse, 90% of labeled 
HLA-G was degraded after the 6-h chase (Fig. 2 B, lanes 7 and 8). 
Only a small portion of endoglycosidase H (endo H)–sensitive 
HLA-G complexes remains at 6 h of chase (Fig. 2 B, lanes   
7 and 8). We conclude that surface expression and stability of 
HLA-G are sensitive to the presence of US10, whereas the   
classical class I MHC molecules are not affected by US10.
To  investigate  whether  the  proteasome  is  involved  in 
US10-mediated  degradation  of  HLA-G,  we  monitored 
HLA-G levels in US10-expressing JEG3 cells in the presence 
of the proteasome inhibitor ZL3VS (Jones et al., 1996; Wiertz 
et al., 1996a). In JEG3 cells, HLA-G is a stable type I mem-
brane glycoprotein with scant reduction in the amounts of 
biosynthetically labeled HLA-G, even after 12 h of chase. 
Little if any HLA-G remains after the 12-h chase period in 
Figure 2.  HLA-G dislocation and degradation in the presence of 
US10. (A) US10 degrades HLA-G. Lysates from JEG3 cells expressing HA-
tagging US3, US9, or US10 were analyzed by immunoblotting with the 
indicated antibodies. (B) US10-expressing JEG3 cells were metabolically 
labeled for 20 min and chased for 6 h. Assembled HLA-G molecules were 
immunoprecipitated with MEM-G/9 and treated with endo H where indi-
cated. Immunoprecipitation from NP-40 lysates of JEG3 cells (C) and HeLa 
cells (D) pulse-labeled for 20 min and chased for the indicated time points 
in the absence (lanes 1–6) or presence (lanes 7–9) of 50 µM ZL3VS were 
performed with MEM-G/1 antibodies. A representative result of two inde-
pendent experiments is shown.2036 HCMV US10 targets HLA-G | Park et al.
tail or both the transmembrane domain and the cytoplasmic 
tail of US10, respectively, were deleted (Fig. 3 A, top). These 
mutant proteins remain endo H sensitive during chase periods 
of up to 4 h (Fig. 3 B). In contrast to cells that express wild-
type US10, cells that express the US10 truncation mutants 
Characterization of the cytoplasmic tail residues of US10 
critical for degradation of HLA-G
To identify the regions of US10 responsible for mediating the 
degradation of HLA-G, we constructed two truncation mu-
tants, US10CT and TM+CT, in which the cytoplasmic 
Figure 3.  Characterization of the cytoplasmic determinants of US10 responsible for the degradation of HLA-G. (A) Schematic representation 
of the chimeras of US10 and HLA-G. TM, transmembrane; CT, cytoplasmic tail; filled, HLA-G; open, HLA-A2. (B) Stability and maturation of US10 and its 
deletion mutants. HeLa cells were transfected with US10, US10CT or US10TM+CT. Cells were labeled for 15 min and chased for the indicated times. 
Immunoprecipitated proteins were digested (+) or not digested () with endo H. (C) HLA-G surface expression in JEG3 and HeLa cells expressing US10 
chimeras. HeLa and JEG3 cells were transiently transfected with the individual cDNAs encoding the US10 deletion mutants. After 48 h, cell surface ex-
pression of HLA-G was analyzed by cytofluorimetry using MEM-G/9. Dashed line, no US10; solid line, US10; bolded line, transfectants. (D and E) Stability 
of HLA-G in cells expressing wild-type US10, mutants, or HA-TEV epitope–tagged constructs of US10. (F and G) The tri-leucine motif of the US10 cyto-
plasmic tail is critical for degradation of HLA-G. Expression of HLA-G and the indicated point mutants of US10 were analyzed by cytofluorimetry and 
immunoblotting using MEM-G/9 and MEM-G/1 antibodies. Data are from three independent experiments.JEM VOL. 207, August 30, 2010 
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The cytoplasmic tail  
of HLA-G is required for US10  
to exert its function
The sensitivity of HLA-G to degra-
dation facilitated by US10 is intrinsic 
to HLA-G. The cytoplasmic tail of 
HLA-G is much shorter (6 amino   
acids; RKKSSD) than that of the classi-
cal class I MHC products (Geraghty 
et al., 1987; Fig. 3 A, bottom). To 
address the role of HLA-G’s short cy-
toplasmic tail, we generated not only HLA-GCT, which 
lacks the cytoplasmic tail, but also HLA-A2/G tail, a version 
of the classical class I MHC product HLA-A2 equipped with 
the cytoplasmic tail of HLA-G (HLA-A2/G tail; Fig. 3 A, 
bottom).  Expression  levels  of  HLA-A2.1  or  HLA-GCT 
were not affected by US10 (Fig. 4 A), whereas HLA-A2/G 
tail behaved like HLA-G (Fig. 4, B and C). We examined 
surface expression of these mutants in US10-expressing HeLa 
cells.  Deletion  of  the  cytoplasmic  tail  of  HLA-G  (HLA-
GCT) prevented its down-regulation by US10, whereas 
surface expression of HLA-A2/G tail was affected by US10 
like HLA-G (Fig. 4 C). HLA-E is a human nonclassical class I 
MHC molecule and is similar to HLA-G with the exception 
of an extension of the cytoplasmic tail when compared with 
HLA-G (32 aa instead of 6 aa). We examined whether the 
level of HLA-E protein expression is affected by US10   
(Fig. S1). HLA-G or HLA-E–expressing HeLa cells were 
transfected with US10 and examined by immunoblotting with 
anti-HLA-G  or  anti-HLA-E  antibodies.  Protein  levels  of 
HLA-G were significantly affected by US10, whereas the 
HLA-E level was only slightly reduced. We conclude that 
within the context of a human class I MHC molecule the 
short cytoplasmic tail sequence of HLA-G is necessary and 
sufficient to allow US10-mediated degradation and that US10 
specifically targets HLA-G.
showed normal levels of HLA-G at the cell surface (Fig. 3 C). 
Even though the levels of expression of wild-type and mutant 
proteins were comparable, the levels of HLA-G heavy chain, 
assessed by immunoblotting, were similar for cells that express 
the US10 truncation mutants and HLA-G transfectants pro-
duced in the absence of US10 (Fig. 3, D and E). The cytoplas-
mic tail of US10 thus functions as a signal that targets HLA-G 
for degradation.
To narrow the determinants within the cytoplasmic tail es-
sential to the down-regulatory capacity of US10, we gener-
ated a construct that lacks residues 177–185 (US10177-185;   
Fig. 3 A, top). This mutant showed a wild-type pattern of 
degradation of HLA-G (Fig. 3, D and F). Thus, the motif be-
tween amino acids 171 and 176 (TRSLLL) of US10 appeared 
critical for the degradation of HLA-G. We then established the 
importance of the leucine residues 174–176 for degradation   
of HLA-G. We substituted the first leucine residue (in bold; 
TRSALL), the first and second leucine residues (TRSAAL), 
and all three leucine residues (TRSAAA) with alanine (Fig. 3 A, 
top). The version of US10 that lacks two leucine residues re-
stored HLA-G protein levels, and its presence is permissive for 
cell surface expression of HLA-G. Replacement of all three 
leucines rendered US10 completely inactive (Fig. 3, F and G). 
We conclude that the tri-leucine motif in the cytoplasmic tail 
of US10 is crucial to target HLA-G for degradation.
Figure 4.  US10 uniquely targets the 
short cytoplasmic tail of HLA-G.  
(A and C) HeLa cells expressed HLA-G, HLA-
GCT, or HLA-A2.1 were transiently trans-
fected with the indicated constructs and 
observed for protein expression or cell  
surface expression of HLA-G by immuno-
blotting or cytofluorimetry with the in-
dicated antibodies (A: -HLA-G, -HA, or 
--actin; C: -HLA-G or BB7.2). (B) HeLa 
cells expressing US10 were transiently trans-
fected with wild-type HLA-A2 or HLA-A/G 
tail and examined for protein expression of 
HLA-A2 by immunoblotting with HLA-A2 
antibody. Dashed line, control Ab; solid  
line: transfectants alone; bolded line: 
transfectants+US10. Data are representa-
tive of similar experiments performed at 
least two times.2038 HCMV US10 targets HLA-G | Park et al.
Although the failure to recover 
these components of the dislocation 
complex is a negative result, we note 
that the recovery of US10 in these 
experiments  is  very  similar  to  that 
recorded for US11, based on compa-
rable methionine content of US11 and US10. We have thus 
far been unable to positively identify interactors of US10 that 
might account for its ability to dislocate HLA-G. The failure 
to recover the well-documented interactors of US11, as well 
as the strikingly different kinetics with which dislocation of 
HLA-G occurs relative to classical class I molecules, also 
compared with cells that express US2, suggests that US10 
employs a mechanism distinct from that used by US2 and 
US11. In much the same way that the early aspects of US2- 
and  US11-dependent  dislocation  operate  through  recruit-
ment  of  different  machinery  (Lilley  and  Ploegh,  2004; 
Loureiro et al., 2006; Mueller et al., 2006), the US10 mole-
cule may well use a different pathway to execute destruction 
of HLA-G molecules.
US10 prevents HLA-G-mediated NK cell inhibition
HLA-G has unique immunomodulatory properties through   
its ability to inhibit NK cell–mediated cytotoxicity (Pazmany   
et al., 1996; Navarro et al., 1999; Sasaki et al., 1999). We there-
fore examined the ability of US10 to interfere with HLA-G–
mediated inhibition of NK cytotoxicity. In previous studies, 
killing of the class I–negative human B cell line 721.221   
by peripheral NK cells is inhibited by the expression of   
HLA-G (Pazmany et al., 1996; Ponte et al., 1999; Söderström   
et al., 1997). Peripheral NK (pNK) cells were coincubated 
with 721.221, 721.221/HLA-G, or 721.221/HLA-G that 
The mechanism of degradation of HLA-G by US10  
is distinct from that used by US2 and US11 for classical 
class I MHC products
We next investigated the physical association of US10 and 
HLA-G  in  digitonin  lysates  of  metabolically  labeled  cells.   
In anti-HLA-G immunoprecipitates, both US10 and its trun-
cation mutants were present (Fig. 5 A, lanes 2–4), as verified 
by a second round of immunoprecipitation with antibodies 
that recognize the tagged versions of US10 (Fig. 5 A, lanes 
6–8). The luminal segment of US10 is therefore sufficient for 
its interaction with HLA-G, a situation analogous to the in-
teraction of US2, US3, and US11, all of which interact with 
their client proteins via their luminal domains.
We have mapped in some detail the protein complexes re-
quired for US11-dependent dislocation of classical class I mol-
ecules. US11 associates in stable fashion with Sel1L, Derlin1, 
and Derlin2 (Lilley and Ploegh, 2004; Mueller et al., 2006).   
A similar experiment conducted for US10 fails to recover Sel1L, 
Derlin1, or Derlin2 (Fig. 5 B). We confirmed these results by 
using short hairpin RNA (shRNA) for Sel1L and by transfec-
tion with a dominant-negative construct of Derlin1 or Derlin2 
(Lilley and Ploegh, 2004; Mueller et al., 2006). In US11- 
expressing HeLa cells cotransfected with either Derlin1GFP  
or Sel1L shRNA, we observed stabilization of the class I HC 
(Fig. 5 C, bottom). In contrast, HLA-G was degraded in US10-
dependent fashion under the same conditions (Fig. 5 C, top).
Figure 5.  US10 selectively targets 
HLA-G molecules for degradation by a 
mechanism distinct from that used by 
HCMV US11. (A) The luminal domain of 
US10 is required for the interaction of 
HLA-G. Cells transfected with indicated 
cDNA were labeled with [35S] methionine 
and cysteine for 1 h. The anti-HLA-G  
immunoprecipitate was analyzed directly 
(lanes 1–4) or reimmunoprecipitated after 
dissociation of the initial immunoprecipi-
tate using anti-HA antibodies (lanes 5–8). 
(B) US10 does not obviously associate with 
the dislocation components recruited by 
US11: Sel1L and Derlin1, 2. Immunoprecipi-
tations from digitonin lysates were per-
formed with anti-HA antibodies. The 
anti-HA immunoprecipitates were either 
analyzed directly or reimmunoprecipitated 
using the indicated antibodies. (C) Expres-
sion of a Derlin1/2 dominant-negative 
construct or shRNA Sel1L does not inhibit 
US10-mediated HLA-G degradation. Data 
are representative of two experiments.JEM VOL. 207, August 30, 2010 
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The functional consequences of HLA-G down-regulation 
include, yet may not be limited to interference with HLA-G-
mediated NK cell inhibition. This is consistent with previous 
studies that documented a role of HLA-G in the control of 
feto-maternal interactions (Carosella et al., 2000) and the more 
recently described involvement of HLA-G in the regulation of 
both DC differentiation (Romani et al., 1994) and prolifera-
tion of T cells (Le Gal et al., 1999; Lila et al., 2001). Therefore, 
we must consider the possibility that HCMV targets these   
aspects of immune recognition no less attentively than it per-
turbs antigen presentation via classical class I MHC molecules. 
The ability to exploit US10 to achieve selective elimination of 
HLA-G may be useful as a tool to establish in greater detail the 
immunological function of HLA-G. Our experiments do not 
address the impact of US10 on the generation of soluble HLA-G, 
the function of which remains to be established at physio-
logical concentrations.
Why HCMV should use several different gene products   
to target a common set of substrates—class I MHC products—
remains a mystery. Earlier work has shown that inhibition of 
TAP via US6 compromises HLA-G expression (Jun et al., 
2000). Variable effects of US2, US3, and US11 on expression 
of HLA-G have been reported as well, but these experiments 
often rely on overexpression US gene products, mostly using 
vaccinia virus vectors, and do not examine their effects in the 
context of HCMV-infected cells (Jun et al., 2000; Barel et al., 
2003). Because HCMV can infect many different cell types, it 
is possible that each cell type prefers a distinct mode of disloca-
tion of class I MHC products, depending on the dislocation or 
ER retention machinery available. The mere presence of the 
HCMV gene products is sufficient to mediate accelerated de-
struction, and consequently these small viral membrane pro-
teins must co-opt host machinery to achieve their goals. 
HLA-G shows a pattern of expression markedly different from 
that of classical class I MHC products. Although HLA-G was 
first described as a molecule whose expression is restricted to 
extravillous trophoblasts, it is now appreciated that dendritic 
cells and other cell types can express HLA-G and may do so to 
regulate the activation of regulatory T cells through interaction 
with ILT4 (Ristich et al., 2007; Liang et al., 2008). The ability 
of CMV to target this nonclassical class I molecule for degrada-
tion suggests that HCMV maintains tight control over the ex-
pression not only of classical class I molecules, but also of those 
whose functions may be more specialized. What could be the 
selective advantage that accrues to HCMV through expression 
of US10, and hence down-modulation of HLA-G? Obviously, 
relieving inhibition of NK cells and inviting cytolytic attack   
on HCMV-infected, US10-positive cells would seem coun-
terintuitive, unless one assumes that cytolysis may assist in the 
release of already assembled intracellular virus particles to facili-
tate further spreading of the infection. In many instances, activa-
tion of NK cells need not lead to cytolysis, but rather results in 
altered cytokine production instead (Pazmany et al., 1996; Li   
et al., 2009; Ponte et al., 1999). Any action that would alter the 
activation status of NK cells, more specifically of those that ex-
press several inhibitory receptors, might create an environment 
coexpresses US10 at a 10:1 E/T ratio for 5 h at 37°C. We ob-
served that US10 also degrades HLA-G in 721.221 cells (Fig. 6 A) 
and that HLA-G–expressing 721.221 cells are resistant to cyto-
toxic activity of pNK cells compared with the parental 721.221 
cell line (Fig. 6 B). US10 blocked the inhibition of NK lytic 
activity by HLA-G, as did addition of mAb specific for HLA-G 
(Fig. 6 B). We conclude that US10 interferes with the ability of 
HLA-G to regulate NK cell activity.
DISCUSSION
A deglycosylated intermediate of HLA-G is present in US10-
expressing cells exposed to proteasome inhibitors, but is   
evident only with considerable delay after synthesis. The 
properties of the tails of HLA-G and US10 are essential for 
dislocation to occur, yet neither the HLA-G tail nor the US10 
tail resemble those of classical class I MHC molecules or those 
of US2 and US11, respectively: the tri-leucine cluster in the 
US10 cytoplasmic tail is without an obvious counterpart in 
US2 or US11. In addition, the physical association of US10 
with HLA-G through the luminal domain of US10 may have 
contributed to a small extent to the retention of HLA-G com-
plexes in the ER (Fig. 2 B).
Figure 6.  US10 interferes with HLA-G-mediated Natural Killer cell 
cytotoxic activity. (A) Expression level of HLA-G by US10 in 721.221 cells 
was analyzed by immunoblotting with MEM-G/1 antibodies. (B) Target 
cells were stained with DiOC18 (3) for 30 min and then pNK cells were 
coincubated with different target cells at a 10:1 ratio (Effect: Target) for  
5 h. After incubation time, cells were stained with propidium iodide for 
dead cells for 10 min and analyzed by cytofluorimetry. Data are represen-
tative of three experiments.2040 HCMV US10 targets HLA-G | Park et al.
with 5% skim milk in PBS with 0.1% Tween-20 for 2 h, and probed with   
the appropriate antibodies for 4 h. Membranes were washed three times   
with PBS with 0.1% Tween-20 and incubated with horseradish peroxidase–
conjugated streptavidin for 1 h. The immunoblots were visualized with ECL 
detection reagent.
Cytotoxicity assay. Target cells were stained with DiOC18 (3) (Invitrogen) 
for 30 min, and then washed with PBS 3 times. Effect cells were co-incubated 
with different target cells for 5 h. Effect cells alone and target cells alone were 
prepared for data analysis. After the incubation period, propidium idodide was 
added immediately into the co-cultured cells and analyzed by Flow cytometry.
Online supplemental material. Fig. S1 shows that expression of HLA-G 
is slightly reduced by US10. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20091793/DC1.
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more favorable for HCMV, and herein might provide a ratio-
nale for why HCMV has retained the US10 gene as a pos-
sible immunoevasin. The ability of HCMV to be passed from 
mother to child in the course of pregnancy may well be related 
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